Tumor Microenvironment-Specific Functional Nanomaterials for Biomedical Applications
- PMID: 33419489
- DOI: 10.1166/jbn.2020.2976
Tumor Microenvironment-Specific Functional Nanomaterials for Biomedical Applications
Abstract
In recent years, considerable achievements have been made to motivate the construction of tumor microenvironment (TME)-specific functional nanomaterials, which can effectively respond to the inherent pathological and physicochemical conditions in diseased regions to improve the specificity of imaging and drug delivery. Until now, various nanoarchitectures have been designed to combat cancer effectively and specifically. This review summarizes the latest developments in TME-specific theranostic nanoplatforms based on multifunctional nanomaterials that hold potential for achieving the targeted recognition at tumor sites. Recent progress and achievements have also been summarized for nanosystems that can specifically respond to the TME with various stimulus-responsive strategies and their applications for drug delivery, diagnosis, treatment, and synergistic theranostics of cancer. This review emphasizes the significance of functional nanomaterials in response to tumor stimuli to enhance anticancer treatment efficiency and facilitate development in extensive research fields, including nanoscience, biomedicine, and clinical applications.
Similar articles
-
All-in-one nanotheranostic platform based on tumor microenvironment: new strategies in multimodal imaging and therapeutic protocol.Drug Discov Today. 2024 Jul;29(7):104029. doi: 10.1016/j.drudis.2024.104029. Epub 2024 May 16. Drug Discov Today. 2024. PMID: 38762088 Review.
-
Two-dimensional nanomaterials for tumor microenvironment modulation and anticancer therapy.Adv Drug Deliv Rev. 2022 Aug;187:114360. doi: 10.1016/j.addr.2022.114360. Epub 2022 May 28. Adv Drug Deliv Rev. 2022. PMID: 35636568 Review.
-
2D Nanomaterials for Cancer Theranostic Applications.Adv Mater. 2020 Apr;32(13):e1902333. doi: 10.1002/adma.201902333. Epub 2019 Jul 28. Adv Mater. 2020. PMID: 31353752 Review.
-
Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?Acta Biomater. 2021 Apr 15;125:1-28. doi: 10.1016/j.actbio.2021.02.030. Epub 2021 Feb 24. Acta Biomater. 2021. PMID: 33639310 Review.
-
Manganese dioxide (MnO2) based nanomaterials for cancer therapies and theranostics.J Drug Target. 2021 Nov;29(9):911-924. doi: 10.1080/1061186X.2020.1815209. Epub 2021 Aug 20. J Drug Target. 2021. PMID: 33063538 Review.
Cited by
-
Challenges in Coopted Hydrophilic and Lipophilic Herbal Bioactives in the Same Nanostructured Carriers for Effective Bioavailability and Anti-Inflammatory Action.Nanomaterials (Basel). 2021 Nov 12;11(11):3035. doi: 10.3390/nano11113035. Nanomaterials (Basel). 2021. PMID: 34835798 Free PMC article.
-
Concepts and Application of DNA Origami and DNA Self-Assembly: A Systematic Review.Appl Bionics Biomech. 2021 Nov 16;2021:9112407. doi: 10.1155/2021/9112407. eCollection 2021. Appl Bionics Biomech. 2021. PMID: 34824603 Free PMC article. Review.
-
Synthesis and Characterization of Magnetic Drug Carriers Modified with Tb3+ Ions.Nanomaterials (Basel). 2022 Feb 26;12(5):795. doi: 10.3390/nano12050795. Nanomaterials (Basel). 2022. PMID: 35269283 Free PMC article.
-
Inhibition of growth of hepatocellular carcinoma by co-delivery of anti-PD-1 antibody and sorafenib using biomimetic nano-platelets.BMC Cancer. 2024 Feb 26;24(1):273. doi: 10.1186/s12885-024-12006-1. BMC Cancer. 2024. PMID: 38409035 Free PMC article.
-
Identification of Molecular Fragments in Equilibrium with Polysiloxane Ultrasmall Nanoparticles.Nanomaterials (Basel). 2022 Feb 22;12(5):738. doi: 10.3390/nano12050738. Nanomaterials (Basel). 2022. PMID: 35269226 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical